Telomerase as a tumor-associated antigen for cancer immunotherapy

Author： Patel Kunal P.   Vonderheide Robert H.  

Publisher： Springer Publishing Company

ISSN： 0920-9069

Source： Cytotechnology, Vol.45, Iss.1-2, 2004-06, pp. : 91-99

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prognostic Role of Tumor-Associated Proteases in Colorectal Cancer

By Kushlinskii N.  

Bulletin of Experimental Biology and Medicine, Vol. 154, Iss. 3, 2013-01 ,pp. : 365-369

Springer Publishing Company

Access to resources Recommend Favorite

Recognition of gp43 Tumor-Associated Antigen Peptide by both HLA-A2 Restricted CTL Lines and Antibodies from Melanoma Patients

By Takahashi T.   Irie R.F.   Morton D.L.   Hoon D.S.B.  

Cellular Immunology, Vol. 178, Iss. 2, 1997-06 ,pp. : 162-171

Academic Press

Access to resources Recommend Favorite

Telomerase and cancer

By Shay J.W.  

Trends in Genetics, Vol. 12, Iss. 11, 1996-11 ,pp. : 486-487

Elsevier

Access to resources Recommend Favorite

DNA damage of tumor-associated lymphocytes and total antioxidant capacity in cancerous patients

By Liu X.   Zhao J.   Zheng R.  

Mutation Research/Genetic Toxicology and Environmental Mutagenesis, Vol. 539, Iss. 1, 2003-08 ,pp. : 1-8

Elsevier

Access to resources Recommend Favorite

A Heterologous 3-D Coculture Model of Breast Tumor Cells and Fibroblasts to Study Tumor-Associated Fibroblast Differentiation

By Kunz-Schughart L.A.   Heyder P.   Schroeder J.   Knuechel R.  

Experimental Cell Research, Vol. 266, Iss. 1, 2001-05 ,pp. : 74-86

Elsevier

Access to resources Recommend Favorite